Inventor · disambiguated record
Marc Nazare
Also filed as: NAZARE MARC · NAZARÉ MARC
36 granted patents·11 pending applications·443 citations·filing 2001–2021
97Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND14SANOFI SA9NAZARE MARC4AVENTIS PHARMA GMBH3MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3
Top patents by PatentIndex Score
47 records- 0199US7910606B2Pyrazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Mar 22, 2011·81 cites·14 claims
- 0298US7067665B2Oxybenzamide derivatives useful for inhibiting factor Xa or VllaSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Jun 27, 2006·75 cites·16 claims
- 0395US6953857B2Oxybenzamide derivatives useful for inhibiting factor Xa or viiaAVENTIS PHARMA GMBH·Filed 2001·Granted Oct 11, 2005·69 cites·14 claims
- 0493US8735586B2Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 27, 2014·34 cites·12 claims
- 0590US7465806B2Pyrrole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Dec 16, 2008·18 cites·9 claims
- 0688US8188282B2Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 29, 2012·11 cites·20 claims
- 0788US7317027B2Azaindole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 8, 2008·26 cites·10 claims
- 0887US6906084B2Indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2002·Granted Jun 14, 2005·30 cites·8 claims
- 0986US7223780B2Triazole-derivatives as blood clotting enzyme factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted May 29, 2007·21 cites·9 claims
- 1085US7196103B2Indole derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Mar 27, 2007·27 cites·15 claims
- 1184US7365088B2Indazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Apr 29, 2008·25 cites·11 claims
- 1281US9174993B2N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticalsSANOFI SA·Filed 2012·Granted Nov 3, 2015·8 cites·10 claims
- 1376US8026375B2Transition metal catalyzed synthesis of N-aminoindolesSANOFI AVENTIS·Filed 2009·Granted Sep 27, 2011·2 cites·11 claims
- 1471US11926614B21,2,4-triazole derivatives as tankyrase inhibitorsUNIV OSLO HF·Filed 2019·Granted Mar 12, 2024·1 cites·23 claims
- 1571US8598179B2Pyrazole-carboxamide derivatives as P2Y12 antagonistsNAZARE MARC·Filed 2010·Granted Dec 3, 2013·3 cites·8 claims
- 1671US8283476B2Transition metal catalyzed synthesis of 2H-indazolesHALLAND NIS·Filed 2009·Granted Oct 9, 2012·2 cites·1 claims
- 1770US8426420B2Heterocyclic pyrazole-carboxamidesas P2Y12 antagonistsNAZARE MARC·Filed 2010·Granted Apr 23, 2013·3 cites·3 claims
- 1869US10214530B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2016·Granted Feb 26, 2019·2 cites·14 claims
- 1967US9221784B2Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonistsSANOFI SA·Filed 2013·Granted Dec 29, 2015·1 cites·10 claims
- 2067US2008306056A1PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORSSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 2163US9718825B2N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticalsSANOFI SA·Filed 2014·Granted Aug 1, 2017·1 cites·20 claims
- 2262US7358268B2Imidazole derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Apr 15, 2008·2 cites·5 claims
- 2361US7435747B2Guanidine and amidine derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Oct 14, 2008·1 cites·5 claims
- 2461US2008280946A1Azaindole-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 2555US9221828B2N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticalsSANOFI SA·Filed 2014·Granted Dec 29, 2015·0 cites·17 claims
- 2655US2010216988A1Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazolesSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2755US2005043302A1New indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 2854US11028104B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2020·Granted Jun 8, 2021·0 cites·11 claims
- 2953US7429581B2Pyrazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Sep 30, 2008·0 cites·18 claims
- 3050US8420812B2Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonatesRKYEK OMAR·Filed 2009·Granted Apr 16, 2013·0 cites·15 claims
- 3150US2017050988A1Dotam derivatives for therapeutic useSANOFI SA·Filed 2014·Application pending·0 cites
- 3249US10683309B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2017·Granted Jun 16, 2020·0 cites·11 claims
- 3349US8669266B2Quinoline-carboxamide derivatives as P2Y12 antagonistsNAZARE MARC·Filed 2009·Granted Mar 11, 2014·0 cites·12 claims
- 3448US8088925B2Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitorsWAGNER MICHAEL·Filed 2007·Granted Jan 3, 2012·0 cites·3 claims
- 3548US2015285812A1Fluorescence-Labelled Fatty Acids and Uses ThereofSANOFI SA·Filed 2013·Application pending·0 cites
- 3647US2013072493A1N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALSNAZARE MARC·Filed 2011·Application pending·0 cites
- 3746US2024025849A1Inhibitors of no productionMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2021·Application pending·0 cites
- 3846US2016175304A1N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALSSANOFI SA·Filed 2015·Application pending·0 cites
- 3945US2002173656A1Guanidine and amidine derivatives as factor Xa inhibitorsFiled 2001·Application pending·0 cites
- 4045US2007179122A1Beta-Aminoacid-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 4144US8487109B2Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylatesRKYEK OMAR·Filed 2009·Granted Jul 16, 2013·0 cites·14 claims
- 4244US7741341B2Benzimidazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jun 22, 2010·0 cites·19 claims
- 4343US9346757B2Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formationSANOFI SA·Filed 2013·Granted May 24, 2016·0 cites·9 claims
- 4443US9346762B2Pyrazole derivatives and their use as LPAR5 antagonistsSANOFI SA·Filed 2013·Granted May 24, 2016·0 cites·19 claims
- 4532US12247029B2Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitorsFORSCHUNGSVERBUND BERLIN EV·Filed 2019·Granted Mar 11, 2025·0 cites·15 claims
- 4630US11028084B2Selective inhibitors of gentotoxic steress-induced IKK/NF-κB pathwaysMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2017·Granted Jun 8, 2021·0 cites·19 claims
- 4729US10596168B2Antagonists of the thyroid-stimulating hormone receptor (TSHR)FORSCHUNGSVERBUND BERLIN EV·Filed 2017·Granted Mar 24, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Marc Nazare files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →